Cibus (NASDAQ:CBUS) Stock Rating Upgraded by Wall Street Zen
by Mitch Edgeman · The Markets DailyCibus (NASDAQ:CBUS – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday, Wall Street Zen reports.
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cibus in a report on Friday, September 25th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Cibus has an average rating of “Hold” and an average target price of $9.00.
Read Our Latest Stock Report on Cibus
Cibus Stock Performance
CBUS opened at $1.71 on Friday. The stock’s fifty day simple moving average is $1.69 and its 200 day simple moving average is $1.65. Cibus has a 1-year low of $1.09 and a 1-year high of $4.19. The stock has a market cap of $130.70 million, a PE ratio of -1.04 and a beta of 1.57.
Cibus (NASDAQ:CBUS – Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.10). The company had revenue of $0.99 million for the quarter, compared to the consensus estimate of $1.70 million. Cibus had a negative return on equity of 287.03% and a negative net margin of 2,258.89%. Equities analysts forecast that Cibus will post -1.13 earnings per share for the current year.
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the company. Weiss Asset Management LP acquired a new stake in shares of Cibus during the first quarter worth $1,758,000. Renaissance Technologies LLC grew its stake in shares of Cibus by 42.5% in the first quarter. Renaissance Technologies LLC now owns 98,900 shares of the company’s stock valued at $196,000 after acquiring an additional 29,500 shares in the last quarter. Bank of America Corp DE grew its stake in shares of Cibus by 324.2% in the first quarter. Bank of America Corp DE now owns 74,358 shares of the company’s stock valued at $147,000 after acquiring an additional 56,830 shares in the last quarter. BDT Capital Partners LLC increased its position in Cibus by 1,899.7% during the fourth quarter. BDT Capital Partners LLC now owns 63,410 shares of the company’s stock worth $110,000 after acquiring an additional 60,239 shares during the period. Finally, OMERS ADMINISTRATION Corp bought a new position in Cibus during the first quarter worth about $66,000. Institutional investors own 33.81% of the company’s stock.
About Cibus
Cibus, Inc is an agricultural biotechnology company that develops gene-edited traits for crops. Its technology is designed to make targeted changes to plant genetics without introducing foreign DNA, with the goal of improving crop performance, productivity and sustainability.
The company’s proprietary Rapid Trait Development System (RTDS) platform is used to develop traits for the global seed industry. Cibus has focused on crops including canola, soybean and rice, pursuing applications such as improved disease resistance, herbicide tolerance, reduced pod shatter and other traits intended to support farmers and seed companies.
Founded in 2001, Cibus became a publicly traded company following its 2023 merger with Calyxt, Inc The company is headquartered in San Diego, California, and works with agricultural and seed-industry partners to advance and commercialize gene-edited crop traits.
Featured Articles
- Five stocks we like better than Cibus
- Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?
- The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It
- McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers?
- MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?